How long does reconstituted BPC-157 last?
Reconstituted BPC-157 in bacteriostatic water is typically referenced to a 28-day in-use stability window when stored refrigerated at 2-8 °C. The figure derives from the antimicrobial protection profile of the 0.9% benzyl alcohol preservative paired with the peptide’s chemical-degradation behaviour in aqueous solution under refrigerated conditions.
What the research literature says
The 28-day in-use stability window for reconstituted BPC-157 follows the same framework as other lyophilised peptides handled with bacteriostatic-water reconstitution. The preservative profile underpins the antimicrobial protection; the peptide-stability literature for lyophilised protein formulations (PMID 10967427, PMID 9279875, PMID 15032301) characterises the post-reconstitution degradation pathways — hydrolysis, deamidation, oxidation, aggregation — that determine the chemical-stability ceiling.
BPC-157 is structurally robust relative to many research peptides. The 15-amino-acid sequence carries no methionine or cysteine residues (the most oxidation-susceptible positions in peptide sequences), no internal disulfide bridges, and a glutamate-rich N-terminal segment that contributes to overall structural stability. The published research on the compound has used reconstituted material across multi-week experimental protocols without published reports of mid-experiment activity loss at refrigerated storage.
Extended-stability practice — frozen aliquots in single-use portions — supports longer functional storage when the experimental protocol spans months. The standard aliquoting workflow is documented in the peptide storage guide.
Why this matters in research context
Most BPC-157 research protocols span 4-8 weeks, which sits within or just past the 28-day refrigerated in-use window. The choice for protocols longer than 28 days is between mid-experiment re-reconstitution from a fresh vial, or upfront aliquoting of the initial reconstituted volume into single-use frozen portions. Aliquoting adds a freeze-thaw cycle to each draw but removes the need for mid-experiment vial changes that could introduce batch-to-batch variability. Most multi-month protocols use the aliquot-and-freeze approach.
Related compounds
- BPC-157 10mg — the compound covered by this answer
- Wolverine Stack (BPC-157 + TB-500 blend) — stability framework applies to both components
Related research questions
- How do you store lyophilized peptides?
- How much bacteriostatic water with BPC-157?
- Can you freeze reconstituted peptides?
References
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 2000;203(1-2):1-60. [PMID 10967427]
- Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res 1997;14(8):969-975. [PMID 9279875]
- Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res 2004;21(2):191-200. [PMID 15032301]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. BPC-157 is sold strictly as a research-grade reagent for laboratory and bench research applications.